ARCHIVES

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

CTRC, UCLA Receive Gifts; NCCF Distributes Gold Pins.

March 24, 2000

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997